AdvaMed, CMS Take Conflicting Views On FDA Lab Test Waiver Requirements

FDA will need to consider diverging opinions from outside groups as it develops a policy on the requirements for diagnostic test manufactures seeking permission to market assays to laboratories that are under minimal government oversight